Puma Biotechnology (PBYI)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.98 -0.02 (-0.67%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.00 +0.02 (+0.67%) 18:52 ET
for Mon, Apr 28th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 30,278 | 21,591 | 2 | -29,126 | -59,995 |
| Depreciation Amortization | 11,524 | 11,519 | 9,840 | 11,305 | 10,033 |
| Income taxes - deferred | -7,075 | N/A | N/A | N/A | N/A |
| Accounts receivable | 16,345 | -8,368 | -7,824 | -5,983 | 2,353 |
| Accounts payable and accrued liabilities | -1,380 | 449 | -4,734 | -902 | -7,107 |
| Other Working Capital | -3,535 | -17,854 | -44,496 | -1,309 | 13,160 |
| Other Operating Activity | -7,239 | 19,672 | 31,385 | 46,665 | 42,329 |
| Operating Cash Flow | $38,918 | $27,009 | $-15,827 | $20,650 | $773 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56 | -140 | N/A | N/A | -46 |
| Purchase Of Investment | -76,230 | -23,813 | -4,836 | -38,073 | -29,826 |
| Sale Of Investment | 55,848 | 17,328 | 18,940 | 27,192 | 73,275 |
| Purchase Sale Intangibles | N/A | -12,500 | -7,000 | N/A | -10,000 |
| Other Investing Activity | 0 | -12,500 | -7,000 | 0 | -10,000 |
| Investing Cash Flow | $-20,438 | $-19,125 | $7,104 | $-10,881 | $33,403 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 98,500 | 8,444 |
| Debt Repayment | -33,330 | N/A | N/A | -100,000 | -8,444 |
| Common Stock Issued | 150 | N/A | 12,500 | N/A | 68 |
| Other Financing Activity | -666 | 0 | -277 | -30,431 | -10,000 |
| Financing Cash Flow | $-33,846 | $N/A | $12,223 | $-31,931 | $-9,932 |
| Beginning Cash Position | 86,676 | 78,792 | 75,292 | 97,454 | 73,210 |
| End Cash Position | 71,310 | 86,676 | 78,792 | 75,292 | 97,454 |
| Net Cash Flow | $-15,366 | $7,884 | $3,500 | $-22,162 | $24,244 |
| Free Cash Flow | |||||
| Operating Cash Flow | 38,918 | 27,009 | -15,827 | 20,650 | 773 |
| Capital Expenditure | -56 | -140 | N/A | N/A | -46 |
| Free Cash Flow | 38,862 | 26,869 | -15,827 | 20,650 | 727 |